AIM
BIIB icon

AIA Investment Management’s Biogen BIIB Stock Holding History

AIA Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$638K Buy
2,249
+1,857
+474% +$518K 0.15% 92
2020
Q2 		$105K Hold
392
– – 0.02% 160
2020
Q1 		$124K Hold
392
– – 0.03% 138
2019
Q4 		$116K Buy
392
+52
+15% +$14.4K 0.15% 107
2019
Q3 		$79K Buy
+340
New +$79.2K 0.08% 138

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AIA Investment Management's BIIB Position: Q3 2020 in Review

AIA Investment Management increased its Biogen (BIIB) stake by 474% in Q3 2020, buying an estimated $518K and bringing the position to 2,249 shares worth $638K. The position accounts for 0.15% of the portfolio, ranked #92.

AIA Investment Management first reported a position in BIIB in Q3 2019 and has held it in 5 quarters since. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • AIA Investment Management held 2,249 shares of Biogen worth $638K as of Q3 2020.
  • AIA Investment Management bought 1,857 Biogen shares in Q3 2020, an estimated $518K.
  • Biogen made up 0.15% of AIA Investment Management's portfolio in Q3 2020, its #92 holding.
  • AIA Investment Management first reported a position in Biogen in Q3 2019 and has held it in 5 quarters since.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.